Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the domain of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and therapy are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering potential for more curative